CAPTRUST Financial Advisors
TNYA icon

CAPTRUST Financial Advisors’s Tenaya Therapeutics TNYA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.95K Buy
+13,459
New +$10.2K ﹤0.01% 3239
2025
Q3 		– Sell
-13,566
Closed -$8.29K – 2718
2025
Q2 		$8.29K Sell
13,566
-915
-6% -$466 ﹤0.01% 2501
2025
Q1 		$8.26K Buy
+14,481
New +$14.3K ﹤0.01% 2342
2021
Q4 		– Sell
-26
Closed -$1K – 4906
2021
Q3 		$1K Buy
+26
New +$559 ﹤0.01% 4488

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAPTRUST Financial Advisors's TNYA Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Tenaya Therapeutics (TNYA) in Q2 2026: 13,459 shares worth $9.95K. The stake represents ﹤0.01% of the portfolio and ranks #3239 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in TNYA as recently as Q2 2025.

CAPTRUST Financial Advisors first reported a position in TNYA in Q3 2021 and has held it in 4 quarters since. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • CAPTRUST Financial Advisors held 13,459 shares of Tenaya Therapeutics worth $9.95K as of Q2 2026.
  • Tenaya Therapeutics was a new CAPTRUST Financial Advisors position in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3239 holding.
  • CAPTRUST Financial Advisors first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 4 quarters since.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.